Petco at Goldman Sachs conference: growth phase takes focus

Petco outlined a growth-focused third phase of its turnaround after delivering two consecutive quarters of positive comparable-store sales and reducing net leverage to 2.8x EBITDA from 4.2x at the start of 2025. The company repaid $170 million of debt in nine months, including a $75 million voluntary payment, and is targeting 2.0x leverage before considering shareholder distributions. Management highlighted double-digit veterinary visit growth, healthier-margin digital regrowth and early prototype-store gains, but expects consumer pressure and rational pricing to persist through the end of 2026.

Analysis

WOOF’s equity is now a high-beta claim on execution rather than a simple pet-retail demand recovery. Incremental service utilization, prescription capture and owned-brand mix can lift gross margin without requiring broad-based discretionary spending, while lease renegotiations create a potentially underappreciated fixed-cost offset. The key second-order benefit is that a more integrated customer relationship raises switching costs versus AMZN and WMT, whose price and delivery advantages are less relevant in veterinary, grooming and urgent replenishment occasions.

The near-term valuation debate will hinge on whether growth investments remain self-funded. A sustained positive-comp/SG&A-leverage pattern over the next two quarterly reports could drive disproportionate equity upside because deleveraging lowers both interest burden and perceived refinancing risk; conversely, a modest EBITDA miss would be amplified by the still-material leverage and low share price. Management’s prototype, loyalty and AI claims are not yet independently measurable, so investors should not capitalize them until disclosure shows cohort retention, services attachment, digital contribution margin and remodel payback.

Consensus may be too focused on consumer stress and national price competition. The more relevant risk is veterinary labor productivity: if staffing flexibility improves appointment availability, the existing hospital base can expand profit with limited capital; if wage inflation or clinician attrition rises, the supposed differentiation becomes a fixed-cost liability. Over 6-18 months, the larger opportunity is a rerating from a distressed specialty retailer toward a recurring-services/consumer-health hybrid, but that requires credible evidence that margin gains are not merely the residue of prior cost cuts.

Key Decisions for Investors

• Initiate a small long WOOF only after the next earnings release confirms positive comparable sales, stable-to-improving gross margin and further net-leverage reduction. Target a 6-12 month 50-75% upside from a multiple rerating; exit if comps turn negative or EBITDA guidance is cut, as the equity’s leverage makes downside materially asymmetric.
• Use a relative-value expression: long WOOF / short CHWY in equal dollar amounts over 3-6 months, contingent on WOOF reporting improving service attachment and digital margins. The thesis is that WOOF’s physical-service ecosystem is under-monetized while CHWY remains more exposed to online consumables competition; cover if WOOF’s veterinary visit growth decelerates sharply or CHWY demonstrates sustained margin outperformance.
• Monitor WOOF credit spreads and refinancing terms before scaling equity exposure. A meaningful widening in its debt pricing, despite operating progress, would signal that deleveraging is insufficient and should override the operational turnaround narrative.
• Do not position against AMZN or WMT on this development. Petco’s potential share stabilization is too small to alter either company’s earnings trajectory; the actionable signal is WOOF-specific execution, not a sector-wide competitive shift.